Access disease-level, longitudinal, oncology patient data to inform life science research, development, and commercial strategies with Vantage.
From R&D to post marketing and HEOR, Vantage helps oncology biopharma teams identify opportunities and create enterprise level strategies for specific cancer diagnoses.
Conduct Phase IV and HEOR studies and optimize commercial strategy.
COTA’s database of patients includes longitudinal treatment and outcomes data for oncology patients including:
Explore our collection of clinical research, recent press, podcasts, and more.
At COTA, we believe the future of healthcare is shaped not only by innovation and data but by people. Each...
As incidence rates for many common cancers continue to rise – breast, prostate, colorectal, pancreatic, and others – life sciences...
Four Ways Pharmaceutical Companies Are De-Risking R&D with Real-World Data Pharmaceutical research and development is inherently complex and high-risk. Sponsors...
Discover the power of real-world cancer data for your life science organization.
